Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT and carrier screening. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, HerediT CF Cystic Fibrosis screening test, and the SensiGene RHD Fetal RHD genotyping test.

Property Value
dbo:abstract
  • Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT and carrier screening. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, HerediT CF Cystic Fibrosis screening test, and the SensiGene RHD Fetal RHD genotyping test. In June 2014 the company sold its biosciences unit to Agena Bioscience for up to $35.8 million. In July 2016, it was announced that diagnostic and testing giant LabCorp will acquire Sequenom, paying $2.40 for every outstanding share of Sequenom stock. The sale has been approved by the board of directors but still needs to be approved by shareholders. (en)
dbo:industry
dbo:locationCity
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 21659403 (xsd:integer)
dbo:wikiPageRevisionID
  • 732293932 (xsd:integer)
dbp:keyPeople
  • CEO, Dirk van den Boom
dbp:locationCountry
  • USA
dbp:logo
  • 220 (xsd:integer)
dbp:products
  • MaterniT21 PLUS, MaterniT GENOME, VisibiliT, HerediT CF, HerediT UNIVERSAL, NextView, SensiGene RHD
dbp:services
  • Non-Invasive Prenatal Testing , Carrier Screening
dbp:type
  • Public company
dct:subject
http://purl.org/linguistics/gold/hypernym
rdf:type
rdfs:comment
  • Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT and carrier screening. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, HerediT CF Cystic Fibrosis screening test, and the SensiGene RHD Fetal RHD genotyping test. (en)
rdfs:label
  • Sequenom (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Sequenom (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of